Request Demo
Last update 24 May 2025
BinD-19(Shenzhen BinDeBio Ltd.)
Last update 24 May 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms BIND 19, BIND-19 |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with BinD-19(Shenzhen BinDeBio Ltd.)NCT03156101
A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Relapse or Refractory Acute Lymphoblastic Leukemia and Lymphoma Subjects
NCT03265106
A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Relapse or Refractory Childhood Acute Lymphoblastic Leukemia and Lymphoma Subjects
100 Clinical Results associated with BinD-19(Shenzhen BinDeBio Ltd.)
Login to view more data
100 Translational Medicine associated with BinD-19(Shenzhen BinDeBio Ltd.)
Login to view more data
100 Patents (Medical) associated with BinD-19(Shenzhen BinDeBio Ltd.)
Login to view more data
100 Deals associated with BinD-19(Shenzhen BinDeBio Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-cell lymphoma refractory | Phase 2 | China | 02 Mar 2017 | |
| Recurrent B Acute Lymphoblastic Leukemia | Phase 2 | China | 02 Mar 2017 | |
| refractory acute lymphoid leukemia in relapse | Phase 2 | China | 02 Mar 2017 | |
| Refractory B Acute Lymphoblastic Leukemia | Phase 2 | China | 02 Mar 2017 | |
| CD19 Expressing Malignancies | Phase 2 | China | - | 01 Nov 2016 |
| Pre B-cell acute lymphoblastic leukemia | Phase 2 | China | - | 01 Nov 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free